SomaLogic launches SOMAmer Discovery Service, “SOMAmer Challenge”
October 30, 2014
SomaLogic announced today the launch of a new proteomics service offering aimed at providing its breakthrough protein-binding SOMAmer® reagents to the scientific community based on their specific needs in wide variety of different research uses. The SOMAmer Discovery Service team at SomaLogic will work closely with SomaLogic customers to develop and license “fit-for-purpose” SOMAmer reagents [...]
October 30, 2014
OMAHA, Neb.-- Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced a research agreement with the University of Melbourne to conduct additional clinical validation studies of its Multiplexed ICE COLD-PCRTM (MX-ICP) technology. MX-ICP is a high [...]
Sartorius Opens New Application Center in Shanghai
October 30, 2014
Goettingen | Shanghai -- Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new application center at its Shanghai office last week. Among the guests, representatives from the Shanghai government, customers from the biopharmaceutical industry as well as business partners and the media attended the opening ceremony. With a floor space of [...]
October 30, 2014
Minneapolis -- Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2014. The quarterly dividend will be payable November 24, 2014 to all common shareholders of record on November 10, 2014. Future cash dividends will be considered [...]
Strand Life Sciences to Demonstrate New StrandOmics Features at AMP 2014 Annual Meeting
October 30, 2014
San Fransisco -- Strand Life Sciences (Strand) representatives will demonstrate new capabilities of the company's variant interpretation and reporting software, StrandOmics at the Association For Molecular Pathologist (AMP) 2014 Annual Meeting to be held from November 12th to 15th in National Harbor, Maryland. The 20th anniversary meeting's theme is "Realizing the Dream of Precision Medicine," [...]
Beckman Coulter Genomics Integrates Clarity LIMS
October 29, 2014
DANVERS, MASS. –– Beckman Coulter Genomics, providers of expert genomics solutions to research and healthcare institutions worldwide, has integrated a Genologics Clarity Laboratory Information Management System (LIMS) into their Illumina HiSeq-based workflows to offer Next Generation Sequencing (NGS) with the highest level of data management and methods control. RNA sequencing, target capture, whole-genome sequencing and [...]
October 29, 2014
Pleasanton, CA, USA -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applications. This offering includes a comprehensive lncRNA (long non-coding RNA) design and a full range of custom enrichment offerings. This system was designed to enable researchers to achieve significantly enhanced discovery power and [...]
PerkinElmer Acquires Ceiba Solutions, Inc.
October 29, 2014
WALTHAM, Mass. -- PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the acquisition of Ceiba Solutions, Inc., a sciences and laboratory IT software and services company offering managed IT services and emerging software platforms. PerkinElmer will integrate Ceiba's capabilities into its OneSource® services, which [...]
AXT Commission TESCAN Automated Minerals Analyser at CSIRO
October 29, 2014
AXT Pty Ltd, a leading supplier of high technology equipment for the mining, materials, life science and non-destructive testing markets have recently completed the commissioning of a TESCAN Integrated Minerals Analyser (TIMA) in Perth with the CSIRO’s Mineral Resources Flagship. AXT are TESCAN’s agent in Australia and New Zealand and will supply on going product [...]
ImmunoChemistry Technologies Sells Patent for its Proprietary Technology
October 29, 2014
Minneapolis, MN -- ImmunoChemistry Technologies (ICT), a Twin Cities-based company developing life science tools, has sold its proprietary and patented FLIVO® technology to a private equity firm that focuses on early stage development companies with promising technologies. FLIVO is a powerful tool for quickly detecting apoptosis or programmed cell death in living laboratory animals. Within [...]
